Clinical Trial Update: Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLC

View source ↗

Summary

Clinical trial update for a study using T-cell receptor profiling to predict response to tislelizumab plus chemotherapy as first-line treatment in extensive-sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (unspecified)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Extensive-stage Small-cell Lung Cancer | Status: RECRUITING